Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The overall goal of this research study is to understand how 18F-fluorodeoxyglucose (FDG), a radioactive sugar behaves in head and neck cancer (HNC) and inflammation immediately following injection and at many hours post-injection, with the world\'s first total-body positron emission tomography (PET)/computed tomography (CT) scanner (EXPLORER).
Epistemonikos ID: 2f195553d24b52a08abbc922783e217a967ded64
First added on: May 14, 2024